Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Rose TL, Harrison MR, Deal AM, Ramalingam S, Whang YE, Brower B, Dunn M, Osterman CK, Heiling HM, Bjurlin MA, Smith AB, Nielsen ME, Tan HJ, Wallen E, Woods ME, George D, Zhang T, Drier A, Kim WY, Milowsky MI. Rose TL, et al. Among authors: drier a. J Clin Oncol. 2021 Oct 1;39(28):3140-3148. doi: 10.1200/JCO.21.01003. Epub 2021 Aug 24. J Clin Oncol. 2021. PMID: 34428076 Free PMC article. Clinical Trial.
MRI features of intra-axial histiocytic brain mass lesions.
Luna LP, Drier A, Aygun N, Mokhtari K, Hoang-Xuan K, Galanaud D, Donadieu J, Dormont D, Haroche J, Martin-Duverneuil N. Luna LP, et al. Among authors: drier a. Clin Radiol. 2021 Feb;76(2):159.e19-159.e28. doi: 10.1016/j.crad.2020.09.015. Epub 2020 Oct 17. Clin Radiol. 2021. PMID: 33077156
Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C, Canney M, Vignot A, Boisgard R, Drier A, Huberfeld G, François C, Prigent A, Santin MD, Adam C, Willer JC, Lafon C, Chapelon JY, Carpentier A. Horodyckid C, et al. Among authors: drier a. J Neurosurg. 2017 Apr;126(4):1351-1361. doi: 10.3171/2016.3.JNS151635. Epub 2016 Jun 10. J Neurosurg. 2017. PMID: 27285538
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
Haroche J, Cohen-Aubart F, Emile JF, Maksud P, Drier A, Tolédano D, Barete S, Charlotte F, Cluzel P, Donadieu J, Benameur N, Grenier PA, Besnard S, Ory JP, Lifermann F, Idbaih A, Granel B, Graffin B, Hervier B, Arnaud L, Amoura Z. Haroche J, et al. Among authors: drier a. J Clin Oncol. 2015 Feb 10;33(5):411-8. doi: 10.1200/JCO.2014.57.1950. Epub 2014 Nov 24. J Clin Oncol. 2015. PMID: 25422482 Clinical Trial.
Cerebral tumor or pseudotumor?
Leclercq D, Trunet S, Bertrand A, Galanaud D, Lehéricy S, Dormont D, Drier A. Leclercq D, et al. Among authors: drier a. Diagn Interv Imaging. 2014 Oct;95(10):906-16. doi: 10.1016/j.diii.2014.08.004. Epub 2014 Sep 26. Diagn Interv Imaging. 2014. PMID: 25260711 Free article. Review.
26 results